透析人群中的低钠血症
综述指出透析患者因多途径易发低钠血症,评估细胞外容量状态是病因鉴别首要步骤;营养不良 proxies 和残余肾功能丧失是重要决定因素;血钠越低死亡风险越高,但时间依赖性关联存在U型与线性之争,因果关系未明。
要点
- 透析患者低钠血症常见,评估容量状态是病因鉴别第一步。
- 低BMI、低白蛋白、低肌酐及残余肾功能丧失与低钠相关。
- 血钠越低死亡风险越高,但时间变化关联结论不一。
核心结论
- 透析患者低钠血症与营养不良 proxies 及残余肾功能丧失相关,血钠越低死亡风险越高,但因果关系未确定。
研究设计与样本
- 综述,总结多项大型人群研究及重复测量血钠研究,未报告具体样本量。
主要发现
- 低体重指数、低血清白蛋白、低血清肌酐是透析患者低钠血症的重要决定因素。
- 残余肾功能丧失是透析患者低钠血症的重要决定因素。
- 常规生存模型中血钠越低死亡风险越高;重复测量研究中时间变化血钠与死亡关联呈U型或 inverse linear 不一致。
临床怎么用
- 透析患者发现低钠血症应先评估细胞外容量状态以鉴别病因。
- 关注营养不良 proxies 和残余肾功能对血钠的影响。
局限性
- 低钠血症与死亡关联的因果关系不确定。
- 时间变化血钠与死亡关联研究结论不一致。
- 钠校正是否改善结局、最佳钠目标、年龄等社会人口学因素影响均未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sodium derangements are among the most frequently encountered electrolyte disorders in patients with end-stage renal disease. As dialysis patients are predisposed to hyponatremia via multiple pathways, assessment of extracellular volume status is an essential first step in disentangling potential etiologic factors. In addition, multiple large population-based studies indicate that proxies of malnutrition (e.g., low body mass index, serum albumin, and serum creatinine levels) and loss of residual kidney function are important determinants of hyponatremia in dialysis patients. Among hemodialysis and peritoneal dialysis patients, evidence suggests that incrementally lower sodium levels are associated with increasingly higher death risk, highlighting the long-term risk of hyponatremia. Whereas in conventional survival models incrementally lower serum sodium concentrations are associated with worse mortality in hemodialysis patients, studies that have examined repeated measures of predialysis sodium have demonstrated mixed associations of time-varying sodium with higher mortality risk (i.e., U-shaped vs. inverse linear relationships). Although the causality of the hyponatremia-mortality association in dialysis patients remains uncertain, there are several plausible pathways by which lower sodium levels may lead to higher death risk, including central nervous system toxicity, falls and fractures, infection-related complications, and impaired cardiac function. Areas of uncertainty ripe for future studies include the following: (i) mechanistic pathways by which lower serum sodium levels are linked with higher mortality in dialysis patients, (ii) whether correction of sodium derangements improves outcomes, (iii) the optimal sodium target, and (iv) the impact of age and other sociodemographic factors on hyponatremia-outcome associations.
引用
- Rhee CM, Ayus JC, Kalantar-Zadeh K, et al. Hyponatremia in the Dialysis Population. Kidney Int Rep. 2019. PMID: 31194059. doi:10.1016/j.ekir.2019.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。